About

Home > About

Purpose

The Immunization Economics Community of Practice brings together a wide-ranging set of stakeholders with an interest in the generation and use of economic evidence to help improve immunization programs in low- and middle-income countries. The community is comprised of over 3,000 members worldwide, including researchers, government policymakers, public health practitioners, technical experts from organizations implementing immunization related projects, private sector representatives, academics, and others.

Goals

Foster community

To foster a global community of practice consisting of experts in the field of immunization economics and policymakers interested in evidence-based immunization policy.

Share knowledge

To serve as a knowledge-sharing platform through which members of the community of practice share resources related to immunization value, costing, financing, and efficiency.

Collaborate

To encourage collaboration between members to advance the evidence base on immunization economics, identify best practices in research methodologies, and translate evidence to policy and practice.

Community platforms

Knowledge hub

Access immunization economics related resources as well as the latest news and opportunities.

See all resources

A regular newsletter

Receive regular updates with new resources, events and opportunities in your mailbox by signing up for our newsletter.

Subscribe

COP social media

Join us on our social media platforms Facebook, X, and LinkedIn.

Special Interest Group (SIG)

We convene the SIG for Immunization Economics at the International Health Economics Association (IHEA) Congress.

Read more

Research priorities

The following are research priorities defined by our community of practice during the IHEA Immunization Economics pre-congress in July 2023. Click each of them to read more:

The cost of reaching zero-dose children

The cost, cost-effectiveness, and efficiency of reaching zero dose children in different contexts, including targeted local interventions, campaigns, but also strengthening the PHC system.

The integration of services

Integration of services, even beyond health, as opposed to the incremental cost of adding immunization services, and lessons learned from the C19 pandemic around this.

Making a cost-effectiveness case for vaccines

Cost, cost-effectiveness, and investment cases of new vaccines will remain necessary as they enter the market or as their recommended schedules change.

The rate of return on investing in vaccine stockpiles

The rate of return of investing in stockpiles of vaccines (e.g., yellow fever and cholera vaccines).

Developing subnational economic evidence

Increased focus on developing economic evidence for subnational level stakeholders and implementers.

Building evidence around budget execution

Evidence around budget execution and practical experiences at national and subnational levels, and identifying best practices in improving the use of evidence in planning, budgeting, and decision-making.

Submit your work

Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.

Submit your work

Theory of change

The theory of change below describes how community activities aim to contribute to planning and financing for immunization.